University of Washington spinout TwinStrand has now raised a total of $8.4m in equity and debt to develop its DNA sequencing technology.

Biomolecule classification technology developer Arago Bioscience emerged out of Oxford in April this year and has now been backed by two of the university's funds.

The commercialisation arm of Victoria University of Wellington has secured $6.6m for its spinouts under an initiative funded by local financial services firm Booster.

Oxford Sciences Innovation has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford that has also added GV as a shareholder.

Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.

Brooke Beier has been promoted to vice-president of Purdue's office of technology commercialization, having started there as a project manager in 2013.

Almi Invest and trade union Unionen have both returned with funding for Beactica, a drug discovery company based on Uppsala University research.

Air transit assistance system startup SkyRyse has accrued $25m in seed and series A funding from investors including Stanford University.